Endo Pharma
SUPPRELIN LA
Manufacturer:
Endo Pharma
Name:
SUPPRELIN LA
HCPCS Code Descriptor:
Histrelin implant (supprelin la), 50 mg
Category:
J Code
HCPCS:
J9226
NDC(s):
67979-0002-01
Primary Type:
Growth Disorder
Generic Status:
Single-Source
Route of Administration:
Subcutaneous
About:
SUPPRELIN LA is a Growth Disorder drug manufactured by Endo Pharma and administered via the Subcutaneous route of administration. The J Code: J9226 is aligned to the drug SUPPRELIN LA.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/08
HCPCS Effective Date:
1/1/23
HCPCS Short Description:
Supprelin la implant
Billing and Coding Guide:
https://www.supprelinla.com/pdfs/Surgeon_MVA_Download.pdf
Patient Assistance:
http://www.supprelinla.com/support-center-and-savings.aspx
